HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

multiple Basal cell carcinoma

A genetically heterogeneous trait that confers susceptibility to cutaneous basal cell carcinoma in people of European descent; several susceptibility loci have been mapped. OMIM: 605462.
Also Known As:
Basal cell carcinoma, multiple; Multiple basal cell carcinoma
Networked: 18 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Xeroderma Pigmentosum (Kaposi's Disease)
2. Skin Neoplasms (Skin Cancer)
3. Oral Leukoplakia
4. Odontogenic Cysts (Keratocyst)
5. Basal Cell Nevus Syndrome (Gorlin Syndrome)

Experts

1. Baas, Paul: 2 articles (11/2006 - 02/2003)
2. Aarts, Maureen J B: 1 article (01/2021)
3. Alers, Robert-Jan: 1 article (01/2021)
4. Bekkenk, Marcel W: 1 article (01/2021)
5. Devriese, Lot A: 1 article (01/2021)
6. Kapiteijn, Ellen: 1 article (01/2021)
7. Mosterd, Klara: 1 article (01/2021)
8. Nelemans, Patty: 1 article (01/2021)
9. Reinders, Marie G H C: 1 article (01/2021)
10. Reyners, An K L: 1 article (01/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to multiple Basal cell carcinoma:
1. 1-phenyl-3,3-dimethyltriazene (PDT)IBA
2. temoporfinIBA
3. RetinoidsIBA
4. HhAntag691IBA
5. Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
6. Cytochrome P-450 CYP1A1 (CYP1A1)IBA
7. Parathyroid Hormone (Parathormone)IBA
8. Ointments (Pastes)IBA
9. Fluorouracil (Carac)FDA LinkGeneric
10. Estrogens (Estrogen)FDA Link

Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Chemoprevention
3. Radiotherapy
4. X-Ray Therapy
5. Therapeutics